Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Clancy

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Current Biology : CB|November 10, 2009
ARF6-regulated shedding of tumor cell-derived plasma membrane microvesiclesVandhana Muralidharan-Chari, James Clancy, Carolyn Plou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2007
Development and functional capacity of transplanted rat metanephroiMark Robert Dilworth, Marc James Clancy, Damian Marshall, et al.
Journal of Pharmaceutical Sciences|August 17, 2021
Inhibition of N-Nitrosamine Formation in Drug Products: A Model StudyKausik K Nanda, Steven Tignor, James Clancy, et al.
Frontiers in Endocrinology|June 3, 2026
Osteogenesis imperfecta: a registry-based study of the clinical symptoms of disease in a large cohort of Italian patientsMarina Mordenti, James Clancy, Matthew Dyer, et al.
Cancer Research|March 12, 2009
ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivoVandhana Muralidharan-Chari, Holly Hoover, James Clancy, et al.
Orphanet Journal of Rare Diseases|September 12, 2024
SATURN: assessing the feasibility of utilising existing registries for real-world evidence data collection to meet patients, regulatory, health technology assessment and payer requirementsL Sangiorgi, M Boarini, M Mordenti, et al.
Orphanet Journal of Rare Diseases|February 23, 2023
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping reviewMaria Rapoport, Michael B Bober, Cathleen Raggio, et al.
Science Signaling|March 7, 2013
The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasisAllie H Grossmann, Jae Hyuk Yoo, James Clancy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 16, 2024
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid studyFrancis H Glorieux, Bente Langdahl, Roland Chapurlat, et al.
BMJ Open|December 23, 2021
Anaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) study protocol : a randomised controlled trial comparing primary unassisted patency at 1 year of primary arteriovenous fistulae created under regional compared to local anaesthesiaAlan Jr Macfarlane, Rachel J Kearns, Marc James Clancy, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Current Biology : CB|November 10, 2009
ARF6-regulated shedding of tumor cell-derived plasma membrane microvesiclesVandhana Muralidharan-Chari, James Clancy, Carolyn Plou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 16, 2007
Development and functional capacity of transplanted rat metanephroiMark Robert Dilworth, Marc James Clancy, Damian Marshall, et al.
Journal of Pharmaceutical Sciences|August 17, 2021
Inhibition of N-Nitrosamine Formation in Drug Products: A Model StudyKausik K Nanda, Steven Tignor, James Clancy, et al.
Frontiers in Endocrinology|June 3, 2026
Osteogenesis imperfecta: a registry-based study of the clinical symptoms of disease in a large cohort of Italian patientsMarina Mordenti, James Clancy, Matthew Dyer, et al.
Cancer Research|March 12, 2009
ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivoVandhana Muralidharan-Chari, Holly Hoover, James Clancy, et al.
Orphanet Journal of Rare Diseases|September 12, 2024
SATURN: assessing the feasibility of utilising existing registries for real-world evidence data collection to meet patients, regulatory, health technology assessment and payer requirementsL Sangiorgi, M Boarini, M Mordenti, et al.
Orphanet Journal of Rare Diseases|February 23, 2023
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping reviewMaria Rapoport, Michael B Bober, Cathleen Raggio, et al.
Science Signaling|March 7, 2013
The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasisAllie H Grossmann, Jae Hyuk Yoo, James Clancy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 16, 2024
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid studyFrancis H Glorieux, Bente Langdahl, Roland Chapurlat, et al.
BMJ Open|December 23, 2021
Anaesthesia Choice for Creation of Arteriovenous Fistula (ACCess) study protocol : a randomised controlled trial comparing primary unassisted patency at 1 year of primary arteriovenous fistulae created under regional compared to local anaesthesiaAlan Jr Macfarlane, Rachel J Kearns, Marc James Clancy, et al.
Pageof 3